Professor Sabine Bahn - Chief Medical Officer
Co-founder of Psyomics Ltd
Sabine has dedicated more than 25 years to researching the molecular basis of mental illness, co-authoring more than 200 research papers on disorders including bipolar disorder and major depressive disorder, as well as previously launching the world’s first commercially available diagnostic aid for schizophrenia in conjunction with the NASDAQ-listed diagnostics company MyriadRBM Inc.
As co-founder of Psyomics Ltd, and head of the Cambridge Centre for Neuropsychiatric Research, Sabine is leading a team of scientists working on translating research breakthroughs into blood-based tests for bipolar disorder and major depression, as well incorporating evidence-based mental health research into the development of our digital tools. As a practising psychiatrist at the Peterborough and Cambridge NHS trust, Sabine has direct experience of the clinical need for new digital and biological tools for tackling some of the fundamental challenges in mental health.